Antifungal effects and potential mechanism of bortezomib in combination with fluconazole against Candida albicans
The clinical management of Candida albicans (C. albicans) infections presents considerable problems, intensified by the few therapeutic choices available for this disease. The increasing resistance to fluconazole (FLC) following its widespread clinical use underscores the need for novel therapeutic strategies. Drug rep...